ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990

In Brief: Adamson’s Appointment Official As DCCP Director; NCI Holds Current Spending To 12 Percent Level

October 23, 1981

In Brief: Harris says She Won’t Ease up On Califano’s Antismoking Campaign – It Cost Him His Job

July 27, 1979

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Study Needs 23,000 Women Whose Sisters Have Cancer

September 29, 2006

DCE Board Recompetition Concepts

July 17, 1987